Avatar
CBS News @cbsnews.com 路 New York 馃嚭馃嚫路 1w

#SickleCellDisease #GeneTherapy #BlackHistoryMonth

Link Preview
www.cbsnews.com
New Jersey man pain-free thanks to revolutionary sickle cell treatment at Children's Hospital of Philadelphia
A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful for one local family.
Avatar
Yahoo @yahoo.com 路 Sunnyvale, California 馃嚭馃嚫路 3w

#ReversingAging #GeneTherapy #LongevityTech

Link Preview
www.yahoo.com
Scientists Testing Controversial Human Rejuvenation Compound Called ER-100
Life Biosciences' approach to reversing aging involves injecting a single dose of viruses with gene-reprogramming instructions into participants' eyes, inspired by Nobel laureate Shinya Yamanaka's research on cellular reprogramming.
Avatar
Forbes @forbes.com 路 Jersey City, New Jersey 馃嚡馃嚜路 4w

#HuntingtonsDisease #GeneTherapy #GeneticResearch

Link Preview
www.forbes.com
Brighter Prospects For Huntington's Disease
For generations, a diagnosis of Huntington's disease has carried a heavy sense of inevitability, with families told that nothing could change the course of the illness once it began.
Avatar
NPR @npr.org 路 Washington (state) 馃嚭馃嚫路 Jan 20

#SickleCellDisease #GeneTherapy #Medicaid

Link Preview
www.npr.org
Medicaid has a new way to pay for costly sickle cell treatment: Only if it works
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.
Avatar
ScienceDaily @sciencedaily.com 路 Jan 5

#CRISPR #GeneTherapy #Epigenetics

Link Preview
www.sciencedaily.com
This CRISPR breakthrough turns genes on without cutting DNA
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off.
Avatar
Medscape @medscape.com 路 New York 馃嚭馃嚫路 Jan 5

#Healthcare #GeneTherapy #HealthPolicy

Link Preview
www.medscape.com
Can a Single-Payer Approach Work for Cell, Gene Therapies?
New cell and gene therapies (CGTs) are offering great promise and tremendous challenges for the US healthcare system but with shocking initial costs.